Skip to main content

Table 2 Eradication rates in groups of active and placebo probiotic

From: Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study

Probiotic Active (CI 95%) Placebo (CI 95%) p
Per protocol 89.8% (81-99%) 85.1% (75-96%) p = 0.49
Intention to treat 81.8% (71-92%) 76.9% (65-89%) p = 0.53
  1. Pearson Chi-Square.